1. Long-term safety and tolerability of aripiprazole lauroxil in patients with schizophrenia. (15th August 2018) Authors: Nasrallah, Henry A.; Aquila, Ralph; Du, Yangchun; Stanford, Arielle D.; Claxton, Amy; Weiden, Peter J. Journal: CNS spectrums Issue: Volume 24:Number 4(2019) Page Start: 395 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. F2. CHANGE IN PROLACTIN AND SEXUAL SIDE EFFECTS IN PATIENTS WITH SCHIZOPHRENIA WHO SWITCHED FROM PALIPERIDONE PALMITATE OR RISPERIDONE LONG-ACTING INJECTION TO ARIPIPRAZOLE LAUROXIL. (9th April 2019) Authors: Kelly, Deanna; Claxton, Amy; Bidollari, Ilda; Du, Yangchun Journal: Schizophrenia bulletin Issue: Volume 45(2019)Supplement 2 Page Start: S255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. O1–06–06: Therapeutic effects of long‐acting intranasal insulin detemir for Alzheimer's dementia or mild cognitive impairment. (1st July 2013) Authors: Craft, Suzanne; Claxton, Amy; Baker, Laura; Cholerton, Brenna; Hanson, Angela; Callaghan, Maureen; Trittschuh, Emily; Arbuckle, Matthew Journal: Alzheimer's & dementia Issue: Volume 9:Supplement 4S(2013)Part 3 Page Start: P139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P3–276: Long‐acting intranasal insulin detemir improves working memory for adults with mild cognitive impairment or early‐stage Alzheimer's dementia. (1st July 2013) Authors: Claxton, Amy; Baker, Laura; Hanson, Angela; Cholerton, Brenna; Trittschuh, Emily; Morgan, Amy; Callaghan, Maureen; Arbuckle, Matthew; Behl, Colin; Craft, Suzanne Journal: Alzheimer's & dementia Issue: Volume 9:Supplement 4S(2013)Part 16 Page Start: P657 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. F1‐02‐04: THERAPEUTIC EFFECTS OF INTRANASAL INSULIN AND INSULIN ANALOGUES ON COGNITION AND MRI MEASURES IN MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE. (1st July 2014) Authors: Craft, Suzanne; Claxton, Amy; Hanson, Angela; Cholerton, Brenna; Neth, Bryan; Trittschuh, Emily; Baker, Laura Journal: Alzheimer's & dementia Issue: Volume 10:Supplement 4S(2014)Part 1 Page Start: P126 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clinical Management of Patients with Schizophrenia Treated with Long-Acting Injectable Antipsychotics and Telepsychiatry Use During COVID-19 Pandemic. (April 2022) Authors: Bessonova, Leona; Keane, Elizabeth; Achtyes, Eric; Harvey, Philip D.; Kane, John M.; Saklad, Stephen R.; Trotter, Jeffrey; Claxton, Amy; Hatfield, Tiffany; McGrory, James; Noori, Wahidullah; O'Sullivan, Amy K.; Biber, Joshua E.; Kessler, Asia Sikora; Yarlas, Aaron; Velligan, Dawn I. Journal: CNS spectrums Issue: Volume 27:Number 2(2022) Page Start: 230 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. M105. ACTIGRAPHIC MONITORING OF SLEEP-WAKE CYCLE IN SCHIZOPHRENIA OUTPATIENTS RECEIVING A LONG-ACTING INJECTABLE ANTIPSYCHOTIC: FEASIBILITY AND INITIAL RESULTS FROM A PROSPECTIVE RCT. (18th May 2020) Authors: Yagoda, Sergey; Wolz, Robin; Weiden, Peter J; Claxton, Amy; Yao, Baiyun; Du, Yangchun Journal: Schizophrenia bulletin Issue: Volume 46(2020)Supplement 1 Page Start: S175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Analysis of prolactin and sexual side effects in patients with schizophrenia who switched from paliperidone palmitate to aripiprazole lauroxil. (August 2021) Authors: Kelly, Deanna L.; Claxton, Amy; Bidollari, Ilda; Du, Yangchun Journal: Psychiatry research Issue: Volume 302(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 167 Randomized, Double-Blind, Active-Controlled Study of Starting Aripiprazole Lauroxil with 1-Day Initiation in Acutely Ill Patients with Schizophrenia. (April 2020) Authors: Weiden, Peter J.; Claxton, Amy; Du, Yangchun; Yagoda, Sergey; Walling, David; Kunovac, Jelena Journal: CNS spectrums Issue: Volume 25:Number 2(2020) Page Start: 306 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Safety and Tolerability of Aripiprazole Lauroxil 2-Month Formulation With 1-Day Initiation for Treatment of Schizophrenia in the ALPINE Study. (April 2021) Authors: Bidollari, Ilda; Vasios, Alexa; Claxton, Amy Journal: CNS spectrums Issue: Volume 26:Number 2(2021) Page Start: 158 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗